Lilly announces positive results in the Phase 2 clinical trial of muvallaplalin
youki676
发表于 2024-12-5 03:03:41
1153
0
0
On November 28th, Eli Lilly announced positive results in the Phase 2 clinical trial of muvallaplalin. Muvallaplalin is a once daily oral medication under development for reducing lipoprotein (a) [Lp (a)]. Lp (a) is a genetically related risk factor associated with cardiovascular disease. Research has shown that muvallaplalin can significantly reduce adult Lp (a) levels, achieving the primary endpoint [i.e. percentage change in Lp (a) from baseline to week 12].
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。